Oct 23, 2026 07:30AM
Oct 23, 2026 07:30AM
Oct 19, 2026 06:01AM
Oct 19, 2026 05:30AM
Sep 30, 2026 01:02AM
Sep 30, 2026 01:00AM
Sep 14, 2026 03:00AM FDA accepts Takeda's zasocitinib drug application for plaque psoriasis
Sep 14, 2026 03:00AM
Jul 16, 2026 06:00PM
Jul 16, 2026 06:00PM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Aug 7, 2024 06:45AM
Jun 24, 2024 03:00AM Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies
Jun 17, 2024 06:45AM
Jun 17, 2024 06:45AM
May 31, 2024 09:57AM
Feb 26, 2024 11:30PM
Dec 21, 2023 04:00PM
Dec 21, 2023 04:00PM
Nov 9, 2023 03:50PM Takeda Pharmaceutical (TAK) Announces FDA Approval of ADZYNMA
Oct 3, 2023 04:50PM
Oct 2, 2023 04:35PM
Oct 2, 2023 04:30PM
Sep 25, 2023 08:45AM
Sep 25, 2023 08:44AM
May 25, 2023 04:31PM
Feb 2, 2023 05:40AM Takeda Pharmaceutical (TAK) Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions, Reports Q3
Jan 11, 2023 08:37AM
Jan 11, 2023 08:36AM
Jan 5, 2023 06:46AM
Dec 19, 2022 02:30PM
Dec 8, 2022 06:45AM
Nov 22, 2022 03:57PM
Nov 22, 2022 03:57PM Takeda’s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U.S. Food and Drug Administration
Nov 11, 2022 05:25AM
Nov 11, 2022 02:00AM
Oct 14, 2022 07:30AM
Aug 22, 2022 09:58AM
Aug 22, 2022 09:57AM
Jun 9, 2022 05:10AM
Jun 9, 2022 04:30AM Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial
Apr 22, 2022 08:04AM
Apr 22, 2022 08:00AM
Dec 8, 2021 07:02AM
Dec 8, 2021 07:00AM
Dec 2, 2021 09:49AM
Nov 23, 2021 05:26PM
Nov 23, 2021 05:24PM Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic
Oct 8, 2021 05:41AM

69,045 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All